Chemoinformaics analysis of Nigakihemiacetal C
Molecular Weight | 380.481 | nRot | 1 |
Heavy Atom Molecular Weight | 348.225 | nRig | 21 |
Exact Molecular Weight | 380.22 | nRing | 4 |
Solubility: LogS | -3.44 | nHRing | 1 |
Solubility: LogP | 0.927 | No. of Aliphatic Rings | 4 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 3 |
Atoms Count | 59 | No. of Aliphatic Hetero Cycles | 1 |
No. of Heavy Atom | 27 | No. of Aromatic Carbocycles | 0 |
nHetero | 6 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 2 |
No. of Hydrogen atom | 32 | No. of Saturated Hetero Cycles | 1 |
No. of Carbon atom | 21 | No. of Saturated Rings | 3 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 6 | No. of Arom Bond | 0 |
nHA | 6 | APOL | 61.2194 |
nHD | 3 | BPOL | 36.4426 |
QED | 0.638 |
Synth | 5.355 |
Natural Product Likeliness | 3.38 |
NR-PPAR-gamma | 0.004 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0.017 |
Pgp-sub | 0.786 |
HIA | 0.385 |
CACO-2 | -4.879 |
MDCK | 0.0000663 |
BBB | 0.945 |
PPB | 0.78565 |
VDSS | 1.485 |
FU | 0.209172 |
CYP1A2-inh | 0.005 |
CYP1A2-sub | 0.759 |
CYP2c19-inh | 0.008 |
CYP2c19-sub | 0.923 |
CYP2c9-inh | 0.004 |
CYP2c9-sub | 0.077 |
CYP2d6-inh | 0.002 |
CYP2d6-sub | 0.273 |
CYP3a4-inh | 0.128 |
CYP3a4-sub | 0.659 |
CL | 12.37 |
T12 | 0.188 |
hERG | 0.029 |
Ames | 0.014 |
ROA | 0.258 |
SkinSen | 0.12 |
Carcinogencity | 0.03 |
EI | 0.007 |
Respiratory | 0.895 |
NR-Aromatase | 0.007 |
Antiviral | Yes |
Prediction | 0.580569 |